(NYSE:ARE), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”). A class action […]

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARE GlobeNewswire December 01, 2025 NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf

Vinci Compass Investments Ltd. (NASDAQ: VINP) (“Vinci Compass,” “we,” “the Company,” “us,” or “our”), the controlling company of a leading alternative investments and global solutions provider in Latin America, announced today that it has completed the previously announced acquisition of 50.1% stake in Verde Asset Management (“Verde”), one of Brazil's leading multi-strategy asset managers with

CPaaS becomes an independent business unit, and the executive structure is reorganized to boost agility Zenvia Inc. (NASDAQ: ZENV), the leading cloud-based CX platform in Latin America, empowering companies to transform their customer journeys, today announced another step in its current strategic cycle focused on expanding its SaaS (Software as a Service) solutions. The initiative

Harmonic (NASDAQ: HLIT) today announced that Nimrod Ben-Natan, President and Chief Executive Officer of Harmonic, and Walter Jankovic, Chief Financial Officer, will participate in a fireside chat at the Raymond James 2025 TMT and Consumer Conference in New York City on Monday, December 8, 2025 at 5:40 a.m. PT/8:40 a.m. ET and host investor meetings

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 47,000 of the Company's common shares to two new employees on December 1, 2025 (each, a “Grant”). https://mma.prnewswire.com/media/2543351/ADC_Therapeutics_SA__logo.jpg The Grants were

Atlas Revenue up 30% year-over-year; 75% of Total Q3 Revenue Third Quarter Fiscal 2026 Total Revenue of $628.3 million, up 19% year-over-year Added 2,600 Customers, with Over 62,500 Total Customers as of October 31, 2025 MongoDB, Inc. (NASDAQ: MDB) today announced its financial results for the third quarter ended October 31, 2025. https://mma.prnewswire.com/media/384058/MongoDB_Logo.jpg “MongoDB delivered

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted a stock option to purchase an aggregate of 2,800 shares of Karyopharm's common stock and an aggregate of 15,791 restricted stock units (RSUs) to seven newly-hired employees. These awards were granted as of November 30, 2025

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that the company has completed its previously announced sale of certain non-core Coflex® spinal implant assets and all OUS entities of Paradigm Spine GmbH to Companion Spine, LLC, and its affiliates.

Calamos Investments®* has announced monthly distributions and sources of distributions paid in December 2025 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans. Fund Distribution Payable date Record date Ex-dividend dateCHI (inception 06/26/2002) $0.0950 12/19/25 12/12/25 12/12/25Calamos Convertible Opportunities and Income FundCHY (inception 05/28/2003) $0.1000 12/19/25 12/12/25 12/12/25Calamos